Safety and Effectiveness of Pulsed Field Ablation for Atrial Fibrillation in Patients with Heart Failure: A MANIFEST-PF Sub-analysis
Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF). To assess the outcomes of pulsed-field ablation (PFA) in HF. MANIFEST-PF is a multicenter...
Gespeichert in:
Veröffentlicht in: | JACC. Clinical electrophysiology 2024-05 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF).
To assess the outcomes of pulsed-field ablation (PFA) in HF.
MANIFEST-PF is a multicenter patient-level registry of consecutive patients undergoing PFA for paroxysmal (PAF) or persistent AF (PerAF). In this sub-study, patients were stratified as: no history of HF (no-HF), HF with preserved EF (HF
EF; LVEF≥50%) or HF with reduced/mildly-reduced EF (HF
EF; LVEF |
---|---|
ISSN: | 2405-5018 2405-5018 |
DOI: | 10.1016/j.jacep.2024.05.002 |